Haleon (NYSE:HLN) Cut to “Strong Sell” at Zacks Research

Zacks Research cut shares of Haleon (NYSE:HLN) from a hold rating to a strong sell rating in a report released on Tuesday,Zacks.com reports.

A number of other analysts also recently weighed in on HLN. Rothschild & Co Redburn downgraded shares of Haleon from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Haleon in a report on Thursday, April 30th. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a report on Tuesday, June 30th. Finally, Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a report on Sunday, July 12th. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Haleon presently has a consensus rating of “Moderate Buy”.

Haleon Price Performance

HLN stock opened at $9.72 on Tuesday. The stock’s 50 day moving average is $9.34 and its two-hundred day moving average is $9.85. Haleon has a 52-week low of $8.65 and a 52-week high of $11.28. The company has a market capitalization of $42.83 billion, a PE ratio of 24.94, a P/E/G ratio of 2.28 and a beta of 0.13. The company has a quick ratio of 0.71, a current ratio of 0.92 and a debt-to-equity ratio of 0.47.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Parkside Financial Bank & Trust lifted its stake in Haleon by 101.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock worth $29,000 after purchasing an additional 1,433 shares during the last quarter. Western Wealth Management LLC acquired a new position in Haleon in the first quarter worth $29,000. Annis Gardner Whiting Capital Advisors LLC increased its stake in Haleon by 402.0% during the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 3,002 shares of the company’s stock valued at $30,000 after purchasing an additional 2,404 shares during the last quarter. Geneos Wealth Management Inc. increased its stake in Haleon by 33.0% during the first quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock valued at $50,000 after purchasing an additional 1,203 shares during the last quarter. Finally, Assetmark Inc. raised its holdings in shares of Haleon by 26.6% during the fourth quarter. Assetmark Inc. now owns 5,962 shares of the company’s stock worth $60,000 after purchasing an additional 1,252 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.